Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.

Palacios J, Sarrió D, García-Macias MC, Bryant B, Sobel ME, Merino MJ.

Mod Pathol. 2003 Jul;16(7):674-8.

2.

Molecular evolutionary patterns in breast cancer.

Shackney SE, Silverman JF.

Adv Anat Pathol. 2003 Sep;10(5):278-90. Review.

PMID:
12973049
3.

Differentiation of tumours of ductal and lobular origin: I. Proteomics of invasive ductal and lobular breast carcinomas.

Turashvili G, Bouchal J, Burkadze G, Kolár Z.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Jun;149(1):57-62. Review.

4.

Differentiation of tumours of ductal and lobular origin: II. Genomics of invasive ductal and lobular breast carcinomas.

Turashvili G, Bouchal J, Burkadze G, Kolár Z.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Jun;149(1):63-8. Review.

5.

Histology and immunophenotype of invasive lobular breast cancer. daily practice and pitfalls.

Varga Z, Mallon E.

Breast Dis. 2008-2009;30:15-9. doi: 10.3233/BD-2009-0278. Review.

6.

Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.

Dabbs DJ, Schnitt SJ, Geyer FC, Weigelt B, Baehner FL, Decker T, Eusebi V, Fox SB, Ichihara S, Lakhani SR, Palacios J, Rakha E, Richardson AL, Schmitt FC, Tan PH, Tse GM, Vincent-Salomon A, Ellis IO, Badve S, Reis-Filho JS.

Am J Surg Pathol. 2013 Jul;37(7):e1-11. doi: 10.1097/PAS.0b013e3182918a2b. Review.

PMID:
23759937
7.

Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast.

Yoder BJ, Wilkinson EJ, Massoll NA.

Breast J. 2007 Mar-Apr;13(2):172-9. Review.

PMID:
17319859
8.

Pleomorphic lobular carcinoma of the breast: a morphologically and clinically distinct variant of lobular carcinoma.

Butler D, Rosa M.

Arch Pathol Lab Med. 2013 Nov;137(11):1688-92. doi: 10.5858/arpa.2012-0603-RS. Review.

PMID:
24168512
10.
11.

Pleomorphic lobular carcinoma of the breast: molecular pathology and clinical impact.

Vargas AC, Lakhani SR, Simpson PT.

Future Oncol. 2009 Mar;5(2):233-43. doi: 10.2217/14796694.5.2.233. Review.

PMID:
19284381
12.

Mutations of the human E-cadherin (CDH1) gene.

Berx G, Becker KF, Höfler H, van Roy F.

Hum Mutat. 1998;12(4):226-37. Review.

PMID:
9744472
13.

Lobular breast carcinoma and its variants.

Rakha EA, Ellis IO.

Semin Diagn Pathol. 2010 Feb;27(1):49-61. Review.

PMID:
20306830
14.
15.
16.

Lobular neoplasia: morphology, biological potential and management in core biopsies.

O'Malley FP.

Mod Pathol. 2010 May;23 Suppl 2:S14-25. doi: 10.1038/modpathol.2010.35. Review.

17.

E-cadherin immunohistochemistry in breast pathology: uses and pitfalls.

Canas-Marques R, Schnitt SJ.

Histopathology. 2016 Jan;68(1):57-69. doi: 10.1111/his.12869. Review.

PMID:
26768029
18.

Lobular neoplasia.

King TA, Reis-Filho JS.

Surg Oncol Clin N Am. 2014 Jul;23(3):487-503. doi: 10.1016/j.soc.2014.03.002. Epub 2014 Apr 16. Review.

PMID:
24882347
19.

Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer.

Mastracci TL, Boulos FI, Andrulis IL, Lam WL.

Breast Cancer Res. 2007;9(6):215. Review.

20.

Lobular breast cancer in a CDH1 splice site mutation carrier: case report and review of the literature.

McVeigh TP, Choi JK, Miller NM, Green AJ, Kerin MJ.

Clin Breast Cancer. 2014 Apr;14(2):e47-51. doi: 10.1016/j.clbc.2013.10.007. Epub 2013 Oct 25. Review. No abstract available.

PMID:
24333020

Supplemental Content

Support Center